is glp 1 fsa eligible TrimRX

GLP 1 Therapies May Benefit MPN And MDS Patients PV Reporter In the ACHIEVE 1 phase 3 trial, the oral small molecule GLP 1 receptor agonist orforglipron significantly reduced the glycated hemoglobin level over a period of 40 weeks in adults with early type 2 diabetes. GLP 1 medicines produce adverse events, predominantly gastrointestinal, transient in most. Yet controversy continues surrounding what AEs are rare but real vs. alleged but not rigorously proven in RCTs or real world data. Starting GLP 1 therapy? Here's what your starter kit actually needs. Most people begin their GLP 1 journey focused only on the medication but the tools you pair it with can make Addressing the Shortage of GLP 1 RA and Dual GIP GLP 1 RA Based TherapiesA Systematic Review